These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9474008)

  • 21. Pamidronate.
    Kellihan MJ; Mangino PD
    Ann Pharmacother; 1992 Oct; 26(10):1262-9. PubMed ID: 1421653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercalcemia and childhood cancer: a 7-year experience.
    Kerdudo C; Aerts I; Fattet S; Chevret L; Pacquement H; Doz F; Michon J; Garabedian M; Orbach D
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):23-7. PubMed ID: 15654274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
    Tal A; Graves L
    South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
    Thiébaud D; Jacquet AF; Burckhardt P
    Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE
    Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia.
    Tamion F; Bonmarchand F; Girault C; Chevron V; Leroy J
    Clin Nephrol; 1995 Feb; 43(2):138-9. PubMed ID: 7736680
    [No Abstract]   [Full Text] [Related]  

  • 28. Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.
    Gallacher SJ; Ralston SH; Dryburgh FJ; Logue FC; Allam BF; Boyce BF; Boyle IT
    Postgrad Med J; 1990 Nov; 66(781):918-22. PubMed ID: 2267202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate.
    Profumo RJ; Reese JC; Foy TM; Garibaldi LR; Kane RE
    Transplantation; 1994 Jan; 57(2):301-3. PubMed ID: 8310527
    [No Abstract]   [Full Text] [Related]  

  • 30. Disodium pamidronate versus mithramycin in the management of tumour-associated hypercalcemia.
    Ostenstad B; Andersen OK
    Acta Oncol; 1992; 31(8):861-4. PubMed ID: 1290634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
    Major P; Lortholary A; Hon J; Abdi E; Mills G; Menssen HD; Yunus F; Bell R; Body J; Quebe-Fehling E; Seaman J
    J Clin Oncol; 2001 Jan; 19(2):558-67. PubMed ID: 11208851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.
    Gurney H; Kefford R; Stuart-Harris R
    Lancet; 1989 Jul; 2(8657):241-4. PubMed ID: 2569054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malignancy-associated hypercalcemia].
    Oura S
    Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report.
    Lombardi G; Cabano R; Bollani L; Del Forno C; Stronati M
    Eur J Pediatr; 2009 May; 168(5):625-7. PubMed ID: 18726115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
    Zojer N; Keck AV; Pecherstorfer M
    Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.
    Sangun O; Dundar BN; Erdogan E
    J Pediatr Endocrinol Metab; 2011; 24(1-2):69-70. PubMed ID: 21528818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immobilization hypercalcemia as a complication of polyneuropathy].
    Riehl J; Brandenburg VM; Dietrich CG; Block F
    Nervenarzt; 2000 Aug; 71(8):655-9. PubMed ID: 10996916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immobilization-related hypercalcemia after renal failure in burn injury.
    Peralta MC; Gordon DL
    Endocr Pract; 2002; 8(3):213-6. PubMed ID: 12113635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial.
    Thürlimann B; Waldburger R; Senn HJ; Thiébaud D
    Ann Oncol; 1992 Sep; 3(8):619-23. PubMed ID: 1450043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
    Pecherstorfer M; Steinhauer EU; Rizzoli R; Wetterwald M; Bergström B
    Support Care Cancer; 2003 Aug; 11(8):539-47. PubMed ID: 12783289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.